The Global CalciphylaxisTreatment Market, by Treatment (Drug Therapy, and Hyperbaric OxygenTherapy), by End User (Hospital and Clinics, Homecare, and Ambulatory Centers),and by Region (North America, Latin America, Europe, Asia Pacific, Middle East,and Africa) was valued at US$ 1,097.7 million in 2017 and is projected toexhibit a CAGR of 9.6% over the forecast period (2018 - 2026).
Calciphylaxis is a rare conditioncharacterized by calcification or the aggregation of calcium in a patient’sblood vessels and the development of thrombosis. This can lead to the death ofcells in a patient’s skin and fatty tissues, thereby causing death. Diagnosisof calciphylaxis is symptoms-based and various tests such as skin biopsy, bloodtests, and imaging studies confirm the condition. There is no specifictreatment available for calciphylaxis. Healthcare professionals often focus onbalancing the minerals in the body such as calcium and phosphate that may aidin treatment of the disease. This can be achieved by changing dialysis regimes,medications, or considering surgery for parathyroid glands. Major surgicaltreatments such as parathyroidectomy are mostly recommended for patients withknown primary hyperparathyroidism. However, surgical debridement to removenecrotic tissue and healing of healthy tissue is more widely used, however, itsefficacy is debated.
* The sample copy includes:Report Summary, Table of Contents, Segmentation, Competitive Landscape, ReportStructure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/2251
Doctors also focus on paincontrol, good nutrition, and excellent ulcer care in case the skin has brokendown. Wound management therapies for calciphylaxis include, nonsurgical woundcleansing and Hyperbaric Oxygen Therapy (HBOT). HBOT can be considered as asecond line of treatment incase wounds do not improve. Researchers and keyplayers in the market are focused on finding efficient treatment forcalciphylaxis. According to the Journal of the American Society of Nephrology2017 study, Vitamin K deficiency can have a role in development of calciphylaxis.Moreover, according a study published in 2017 by BioMed Central NephologyJournal, four week supplementation of Vitamin K2 can significantly improvevascular calcification.
Browse 24 Market Data Tables and21 Figures spread through 165 Pages and in-depth TOC on "CalciphylaxisTreatment Market, by Treatment (Drug Therapy, and Hyperbaric Oxygen Therapy),by End User (Hospital and Clinics, Homecare, and Ambulatory Centers), and byRegion (North America, Latin America, Europe, Asia Pacific, Middle East, andAfrica) - Global Forecast to 2026"
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/calciphylaxis-treatment-market-2251
Key Takeaways of the Global CalciphylaxisTreatment Market:
The global calciphylaxistreatment market is expected to witness a CAGR of 9.6% during the forecastperiod, owing to increasing cases of calciphylaxis associated with dialysis.According to the Nephrology Dialysis Transplantation Journal 2017 study, theGerman Calciphylaxis Registry recorded calciphylaxis reporting rate ofapproximately 30 new cases per year among the dialysis patients between 2006 to2015
Among region, North Americacalciphylaxis treatment market is expected to generate maximum revenue duringthe forecast period, owing to increasing demand for kidney transplantationprocedures and rising number of dialysis patients. According to the NationalKidney Foundation, in 2016, around 3,000 patients every month underwent kidneytransplant in the U.S.
Major players operating in theglobal calciphylaxis treatment market include, 3M, Amgen Inc., BSN Medical,ConvaTec Inc., Medtronic Plc., Smith & Nephew Plc., and Laboratoris SanifitS.L.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/2251
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollar opportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
